Skip to content

Released Nov 6, 2025, before the open

10-Q filed Nov 6, 2025, 37 days after period end · 0001704292-25-000024

Q3 2025 · 10-Q
Revenue$115.36M+13.3% vs Q3 2024+5.8% vs Q2 2025
Net Income-$35.96MN/M vs Q3 2024N/M vs Q2 2025
EPS Diluted-$0.03N/M vs Q3 2024N/M vs Q2 2025
Operating Income-$48,822,000N/M
Operating Cash Flowderived-$32,044,000N/M
Free Cash Flowderived-$35,049,000N/M
Margins · derived
Operating margin-42.3%+24.3 pt vs Q3 2024
Net margin-31.2%+9.7 pt vs Q3 2024

What the release said

The release

Same quarter

MetricQ3 2025Q3 2024Q3 2023Q3 2022
Revenue$115.36M$101.85M$69.23M$56.96M
Net Income-$35.96M-$41.67M-$69.15M-$161.19M
EPS Diluted-$0.03-$0.04-$0.07-$0.17

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Zai Lab Ltd · CIK 1704292 · Engraved from SEC EDGAR